This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akin, E.
Right arrow Articles by Steere, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akin, E.
Right arrow Articles by Steere, A. C.

 Previous Article  |  Next Article 

Infection and Immunity, March 2001, p. 1774-1780, Vol. 69, No. 3
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.3.1774-1780.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Expression of Adhesion Molecules in Synovia of Patients with Treatment-Resistant Lyme Arthritis

Evren Akin,1,2,* John Aversa,3 and Allen C. Steere1

Divisions of Rheumatology/Immunology1 and Pediatric Rheumatology,2 Tufts University School of Medicine, New England Medical Center, Boston, Massachusetts, and the New Haven Orthopedic Group, New Haven, Connecticut3

Received 28 August 2000/Returned for modification 11 October 2000/Accepted 8 December 2000

The expression of adhesion molecules in synovium in patients with Lyme arthritis is surely critical in the control of Borrelia burgdorferi infection but may also have pathologic consequences. For example, molecular mimicry between a dominant T-cell epitope of B. burgdorferi outer surface protein A and an adhesion molecule, human lymphocyte function-associated antigen 1 (LFA-1), has been implicated in the pathogenesis of treatment-resistant Lyme arthritis. Using immunohistochemical methods, we examined synovial samples for expression of adhesion molecules in 29 patients with treatment-resistant Lyme arthritis and in 15 patients with rheumatoid arthritis or chronic inflammatory monoarthritis. In Lyme arthritis synovia, endothelial cells showed intense expression of P-selectin and vascular adhesion protein-1 (VAP-1). Expression of LFA-1 was also intense on infiltrating cells, particularly in lymphoid aggregates, and intercellular adhesion molecule-1 (ICAM-1) was markedly expressed on synovial lining and endothelial and infiltrating cells. Moderate expression of vascular cell adhesion molecule-1 (VCAM-1) was seen on synovial lining and endothelial cells, and mild expression of its ligand, very late antigen-4, was apparent in perivascular lymphoid infiltrates. Except for lesser expression of VCAM-1 in Lyme synovia, the levels of expression of these adhesion molecules were similar in the three patient groups. We conclude that certain adhesion molecules, including ICAM-1 and LFA-1, are expressed intensely in the synovia of patients with Lyme arthritis. Upregulation of LFA-1 on lymphocytes in this lesion may be critical in the pathogenesis of treatment-resistant Lyme arthritis.


* Corresponding author. Mailing address: Division of Rheumatology/Immunology, New England Medical Center, NEMC no. 406, 750 Washington St., Boston, MA 02111. Phone: (617) 636-5951. Fax: (617) 636-4252. E-mail: uakin{at}lifespan.org.


Infection and Immunity, March 2001, p. 1774-1780, Vol. 69, No. 3
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.3.1774-1780.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Noda, K., She, H., Nakazawa, T., Hisatomi, T., Nakao, S., Almulki, L., Zandi, S., Miyahara, S., Ito, Y., Thomas, K. L., Garland, R. C., Miller, J. W., Gragoudas, E. S., Mashima, Y., Hafezi-Moghadam, A. (2008). Vascular adhesion protein-1 blockade suppresses choroidal neovascularization. FASEB J. 22: 2928-2935 [Abstract] [Full Text]  
  • Noda, K., Miyahara, S., Nakazawa, T., Almulki, L., Nakao, S., Hisatomi, T., She, H., Thomas, K. L., Garland, R. C., Miller, J. W., Gragoudas, E. S., Kawai, Y., Mashima, Y., Hafezi-Moghadam, A. (2008). Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis. FASEB J. 22: 1094-1103 [Abstract] [Full Text]  
  • Nardelli, D. T., Callister, S. M., Schell, R. F. (2008). Lyme Arthritis: Current Concepts and a Change in Paradigm. CVI 15: 21-34 [Full Text]  
  • Mullegger, R. R., Means, T. K., Shin, J. J., Lee, M., Jones, K. L., Glickstein, L. J., Luster, A. D., Steere, A. C. (2007). Chemokine Signatures in the Skin Disorders of Lyme Borreliosis in Europe: Predominance of CXCL9 and CXCL10 in Erythema Migrans and Acrodermatitis and CXCL13 in Lymphocytoma. Infect. Immun. 75: 4621-4628 [Abstract] [Full Text]  
  • Ghosh, S., Seward, R., Costello, C. E., Stollar, B. D., Huber, B. T. (2006). Autoantibodies from Synovial Lesions in Chronic, Antibiotic Treatment-Resistant Lyme Arthritis Bind Cytokeratin-10. J. Immunol. 177: 2486-2494 [Abstract] [Full Text]  
  • Glasner, J., Blum, H., Wehner, V., Stilz, H. U., Humphries, J. D., Curley, G. P., Mould, A. P., Humphries, M. J., Hallmann, R., Rollinghoff, M., Gessner, A. (2005). A Small Molecule {alpha}4{beta}1 Antagonist Prevents Development of Murine Lyme Arthritis without Affecting Protective Immunity. J. Immunol. 175: 4724-4734 [Abstract] [Full Text]  
  • Guerau-de-Arellano, M., Alroy, J., Huber, B. T. (2005). {beta}2 Integrins Control the Severity of Murine Lyme Carditis. Infect. Immun. 73: 3242-3250 [Abstract] [Full Text]  
  • Ghosh, S., Steere, A. C., Stollar, B. D., Huber, B. T. (2005). In Situ Diversification of the Antibody Repertoire in Chronic Lyme Arthritis Synovium. J. Immunol. 174: 2860-2869 [Abstract] [Full Text]  
  • Amedei, A., Bergman, M. P., Appelmelk, B. J., Azzurri, A., Benagiano, M., Tamburini, C., van der Zee, R., Telford, J. L., Vandenbroucke-Grauls, C. M.J.E., D'Elios, M. M., Del Prete, G. (2003). Molecular Mimicry between Helicobacter pylori Antigens and H+,K+-Adenosine Triphosphatase in Human Gastric Autoimmunity. JEM 198: 1147-1156 [Abstract] [Full Text]